Thermo Fisher Scientific
Waltham, MA 02451
Share:
New Helios Hydra DualBeam System Allows Rapid Ion Beam Switching
Delivers four different ions as the primary beam, including argon, nitrogen, oxygen and xenon. Provides flexibility to analyze samples, improve results and develop improved materials. Suited for milling of carbon-based materials such as graphite used in battery anodes.
Read More »Automation Scheduling Software Offers New Model Building
SAN DIEGO, Calif. – SLAS 2014 – Lab Managers attending the Society for Laboratory Automation and Screening (SLAS) conference and exposition are getting their first look at Thermo Scientific Momentum™ 3.3 automation scheduling software, which offers new features to facilitate set-up and streamline workflows. Thermo Fisher is showcasing the software within booth #517 at SLAS2014, being held...
Read More »Automation Scheduling Software aids setup, streamlines workflow.
Able to control 30+ robots in one system, Momentum™ v3.3 incorporates graphical system layout and instrument integration suite within runtime environment. Users can accommodate quick system and instrument changes by configuring system directly within this solution, and communication settings for all instruments on system can be tested with one click. Integrated container library, support...
Read More »Laboratory Sample Monitor offers wireless operation.
Installed by user on laboratory equipment, Smart-Vue(TM) protects samples by monitoring laboratory parameters such as temperature, CO2 concentration, humidity, and differential pressure. Full audit trail traceability facilitates regulatory compliance, and immediate remote alarm notifications help protect sensitive laboratory samples. Continuously monitoring ambient conditions 24/7, system creates...
Read More »Thermo Fisher Scientific Demonstrates Its FT-IR Instrumentation Gives Increased Confidence in Quality Assurance/Quality Control Testing in New Application Note
Madison, WI - Thermo Fisher Scientific Inc., the world leader in serving science, highlights that its FT-IR instrumentation provides scientists with increased confidence in their results during Quality Assurance/Quality Control (QA/QC) testing. This means scientists are able to focus on handling the ever growing number of samples produced and letting the responsibility for performance...
Read More »Thermo Fisher Scientific and Watercraft Manufacturer Brunswick Equip Patrol Boats with Radiation Detection Systems for Homeland Security
Thermo Scientific Matrix RadSPEC Series enables maritime security forces to quickly detect radioactive threats that could breach nation's coastlines OAKWOOD VILLAGE, Ohio - Thermo Fisher Scientific Inc., the world leader in serving science, today announced a partnership with Brunswick Commercial and Government Products (BCGP) to customize border and harbor patrol watercraft with Thermo Scientific...
Read More »Thermo Fisher Scientific Introduces Accessories for Improved Production-Scale Cell Culture
Accessories make Thermo Scientific Nunc EasyFill Cell Factory more efficient and easier to use ROCHESTER, N.Y. - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new accessories for its Thermo Scientific Nunc EasyFill Cell Factory. The new accessories include a filling tubing set that connects a Nunc(TM) EasyFill(TM) Cell Factory directly to a media bag or...
Read More »Thermo Fisher Scientific FT-IR Spectrometer Named Scientists' Choice Winner for Best New Spectroscopy Product of 2010
MADISON, Wis. - Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific Nicolet iS5 FT-IR spectrometer received a 2011 Scientists' Choice Award for Best New Spectroscopy Product of 2010. The award, voted on by scientists, recognizes the no-compromise, affordable and compact FT-IR spectroscopy capabilities of the rugged instrument. For more...
Read More »Thermo Fisher Scientific Simplifies Water, Environmental and Pharmaceutical Regulatory Compliance and Transforms Process Efficiencies at Nova Biologicals
Implementation of Thermo Scientific LIMS integrated with NextDocs DMS at Nova Biologicals Transforms the Company's Information Management, Improving Efficiencies and Ensuring Compliance with Ever-Growing Industry Regulations PHILADELPHIA - Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Nova Biologicals, one of the nation's largest providers of laboratory...
Read More »Fragment Library accelerates drug discovery lead generation.
Conserving time related to sample and stock solution preparation, Maybridge Ro3 Diversity Fragment Library is available in ready-to-use format. Available in three 500-compound sets, each compound in library is pre-solubilized as 1 mL 10 mM solution, providing 10 Ã-µMol of 95% purity pharmacophore dissolved in analytical grade DMSO. Of 1,500 compounds, many are Maybridge-exclusive...
Read More »Thermo Fisher Scientific Completes FDA Listing and Launches The Applied Biosystems QuantStudio 5 Dx Real-time PCR System for in Vitro Diagnostic Use
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing Carlsbad, Calif., March 25, 2021 /PRNewswire/ -- Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug Administration (FDA) listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The innovative product enables clinical...
Read More »Thermo Fisher Scientific Investments Support Rapidly Increasing Bioprocessing Production
More than $600 million in investments will enable reliable supply of critical materials used to produce new vaccines and biologics WALTHAM, Mass., March 10, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced more than $600 million in capital investments to expand its bioprocessing production capabilities through 2022. These...
Read More »Thermo Fisher Scientific Completes Acquisition of Mesa Biotech
WALTHAM, Mass., Feb. 26, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company. Mesa Biotech is an important part of our strategy to expand the benefits of molecular diagnostics at the point of...
Read More »Thermo Fisher Scientific Announces Oncomine Clinical Research Grant 2021 Call for Submissions
Carlsbad, Calif., Feb. 23, 2021 /PRNewswire/ -- Thermo Fisher Scientific has opened a call for submissions for its Oncomine Clinical Research Grant program to support clinical research. The program aims to assist educational and independent research projects that exhibit excellence in molecular profiling to advance clinical outcomes and support health care providers serving cancer patients....
Read More »Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
Joint venture expands global pharma services capacity for drug development and manufacturing WALTHAM, Mass. and SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Innoforce, a bioinnovation-enabling company, today announced they have signed a joint venture agreement to establish a new pharma services facility...
Read More »Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows
Thermo Fisher and the Biopharmaceutical Analysis Training Laboratory (BATL) of Northeastern University aim to deliver cutting-edge analytical solutions and training programs SAN JOSE, Calif., Nov. 4, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a...
Read More »Thermo Fisher Scientific Extends Collaboration to Advance Biopharmaceutical Discovery and Development
Thermo Fisher and Symphogen continue work to support the development of innovative cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry workflows SAN JOSE, Calif., Oct. 29, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the...
Read More »Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib CARLSBAD, Calif., Aug. 17, 2020 /PRNewswire/ -- Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd....
Read More »Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical
Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan CARLSBAD, Calif., July 8, 2020 /PRNewswire/ -- Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied to the Ministry of Health, Labour and Welfare (MHLW) to expand the use of the Oncomine...
Read More »Thermo Fisher Scientific Extends Collaboration with Biognosys to Enhance Protein Quantitation Mass Spectrometry Workflows
SAN JOSE, Calif., May 26, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, and Biognosys, a leading developer of next-generation proteomics solutions, announce they are continuing their collaboration to advance data independent acquisition (DIA) mass spectrometry-based workflows. Together, the companies have developed a workflow for accurate and flexible...
Read More »